Parathyroid hormone-related peptide-producing multiple myeloma and renal impairment

1Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

A 68-year-old man was hospitalized and examined for renal impairment. A laboratory analysis showed hypercalcemia. Although the serum parathyroid hormone and serum 1-25(OH)2 vitamin D3 levels were not elevated, the serum parathyroid hormone-related peptide (PTHrP) level was increased. Immunoelectrophoresis of the urine and bone marrow aspiration indicated multiple myeloma (MM). He was diagnosed with the coexistence of cast nephropathy and light chain deposition disease by a renal biopsy. Notably, PTHrP expression was detected in the myeloma cells based on immunohistochemistry and in situ hybridization. It is therefore important to examine the PTHrP concentration in MM patients with hypercalcemia.

Cite

CITATION STYLE

APA

Kinomura, M., Shimada, N., Nishikawa, M., Omori, K., Jo, T., Ueda, Y., … Asano, K. (2015). Parathyroid hormone-related peptide-producing multiple myeloma and renal impairment. Internal Medicine, 54(23), 3029–3033. https://doi.org/10.2169/internalmedicine.54.5085

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free